ZOLPIMIST Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Zolpimist, and when can generic versions of Zolpimist launch?
Zolpimist is a drug marketed by Aytu and is included in one NDA. There is one patent protecting this drug.
This drug has eighty-six patent family members in nine countries.
The generic ingredient in ZOLPIMIST is zolpidem tartrate. There are thirty-three drug master file entries for this compound. Forty-six suppliers are listed for this compound. Additional details are available on the zolpidem tartrate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Zolpimist
A generic version of ZOLPIMIST was approved as zolpidem tartrate by ACME LABS on April 23rd, 2007.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for ZOLPIMIST?
- What are the global sales for ZOLPIMIST?
- What is Average Wholesale Price for ZOLPIMIST?
Summary for ZOLPIMIST
International Patents: | 86 |
US Patents: | 1 |
Applicants: | 1 |
NDAs: | 1 |
Drug Prices: | Drug price information for ZOLPIMIST |
What excipients (inactive ingredients) are in ZOLPIMIST? | ZOLPIMIST excipients list |
DailyMed Link: | ZOLPIMIST at DailyMed |
US Patents and Regulatory Information for ZOLPIMIST
ZOLPIMIST is protected by one US patents.
Patents protecting ZOLPIMIST
Buccal, polar and non-polar spray containing zolpidem
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Patented Use: TREATMENT OF TRANSIENT INSOMNIA
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Aytu | ZOLPIMIST | zolpidem tartrate | SPRAY, METERED;ORAL | 022196-001 | Dec 19, 2008 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | Y | Y | ⤷ Sign Up | ||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for ZOLPIMIST
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Aytu | ZOLPIMIST | zolpidem tartrate | SPRAY, METERED;ORAL | 022196-001 | Dec 19, 2008 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Premature patent expiration for: ZOLPIMIST
Expiration due to failure to pay maintenance fee
Patent Number | Tradename | Expiration Date |
---|---|---|
⤷ Sign Up | ZOLPIMIST | ⤷ Sign Up |
International Patents for ZOLPIMIST
See the table below for patents covering ZOLPIMIST around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Canada | 2582018 | PULVERISATEUR ORAL, POLAIRE ET NON POLAIRE, CONTENANT DU ZOLPIDEM (BUCCAL, POLAR AND NON-POLAR SPRAY CONTAINING ZOLPIDEM) | ⤷ Sign Up |
World Intellectual Property Organization (WIPO) | 2004019909 | ⤷ Sign Up | |
Australia | 2003270014 | BUCCAL, POLAR AND NON-POLAR SPRAY OR CAPSULE CONTAINING CARDIOVASCULAR OR RENAL DRUGS | ⤷ Sign Up |
European Patent Office | 1539097 | PULVERISATEUR OU CAPSULE BUCCALE POLAIRE ET NON POLAIRE CONTENANT DES MEDICAMENTS DESTINES A TRAITER DES ALLERGIES OU L'ASTHME (BUCCAL, POLAR AND NON-POLAR SPRAY OR CAPSULE CONTAINING DRUGS FOR TREATING ALLERGIES OR ASTHMA) | ⤷ Sign Up |
Japan | 2010241843 | BUCCAL, POLAR AND NON-POLAR SPRAY OR CAPSULE CONTAINING CARDIOVASCULAR OR RENAL DRUGS | ⤷ Sign Up |
Canada | 2582265 | PULVERISATEUR BUCCAL, POLAIRE ET NON POLAIRE CONTENANT DU PROPOFOL (BUCCAL, POLAR AND NON-POLAR SPRAYS CONTAINING PROPOFOL) | ⤷ Sign Up |
Japan | 2001517689 | ⤷ Sign Up | |
>Country | >Patent Number | >Title | >Estimated Expiration |
Supplementary Protection Certificates for ZOLPIMIST
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
2236132 | 92636 | Luxembourg | ⤷ Sign Up | PRODUCT NAME: ZOLPIDEM ET SES SELS PHARMACEUTIQUEMENT ACCEPTABLES |
2236132 | 122015000006 | Germany | ⤷ Sign Up | PRODUCT NAME: ZOLPIDEM UND PHARMAZEUTISCH VERTRAEGLICHE SALZE DAVON; NAT. REGISTRATION NO/DATE: 83439.00.00 83440.00.00 20120725 FIRST REGISTRATION: BELGIEN BE424286 BE424295 20120718 |
2236132 | CA 2015 00004 | Denmark | ⤷ Sign Up | PRODUCT NAME: ZOLPIDEM OG FARMACEUTISK ACCEPTABLE SALTE HERAF, HERUNDER ZOLPIDEMTARTRAT; NAT. REG. NO/DATE: 47607 OG 47608 20120719; FIRST REG. NO/DATE: (B BE424286 OG BE424295 20120718 |
2236132 | 300714 | Netherlands | ⤷ Sign Up | PRODUCT NAME: ZOLPIDEM EN FARMACEUTISCH AANVAARDBARE ZOUTEN DAARVAN; NATIONAL REGISTRATION NO/DATE: RVG 108438 - 439 20160624; REGISTRATION NO/DATE: BE424286 20120718 BE424295 20120718 |
2236132 | C300714 | Netherlands | ⤷ Sign Up | PRODUCT NAME: ZOLPIDEM EN FARMACEUTISCH AANVAARDBARE ZOUTEN DAARVAN; NAT. REGISTRATION NO/DATE: RVG 108438 - 439 20130624; FIRST REGISTRATION: BE424286BE424295 2012180718 |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |